Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Immunohistochemistry of Cancers Publisher



Ghanadan A1, 2
Authors

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

This chapter provides an overview of mostly malignant tumors of various organs with focus on the most common types. The authors have used their own experience in addition to literature review and have discussed the most common and useful immunohistochemistry markers in the diagnosis and differential diagnosis of various malignant tumors. Novel prognostic markers are also included. © Springer-Verlag Berlin Heidelberg 2015.
Related Docs
View other Related Docs
1. Immunohistochemistry of Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
2. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
3. Genetic and Epigenetic Alterations in Parathyroid Neoplasms, Iranian Journal of Pathology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (8)
Elham Mirzaean (2)
Other Related Docs
4. Co-Incidence of Fibrosarcoma and Esophagus Squamous Cell Carcinoma; a Case of Synchronous Second Primary Neoplasm, Govaresh (2021)
5. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
6. Targeting Regulatory T Cells by Curcumin: A Potential for Cancer Immunotherapy, Pharmacological Research (2019)
7. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
8. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
9. The Paradox of Th17 Cell Functions in Tumor Immunity, Cellular Immunology (2017)
10. Adult Uterine Wilm’S Tumor Miss-Interpreted As Carcinosarcoma: A Case Report, International Journal of Cancer Management (2024)
11. Expression of Pax2 and Pax8 in Wilms Tumor: A Tissue Microarray-Based Immunohistochemical Study, Iranian Journal of Pathology (2021)
12. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
13. An Agent-Based Model of Avascular Tumor Growth: Immune Response Tendency to Prevent Cancer Development, Simulation (2017)
14. Serum Tumor Markers in Chronic Kidney Disease: As Clinical Tool in Diagnosis, Treatment and Prognosis of Cancers, Renal Failure (2016)
15. Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2016)
16. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
17. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
18. Tumor-Infiltrating Lymphocyte Therapy for Lung Cancer and Its Future Paradigms, Expert Opinion on Biological Therapy (2022)
19. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
20. P16ink4a Immunohistochemistry As a Gold Standard for Cervical Cancer and Precursor Lesions Screening, Iranian Journal of Public Health (2020)